Delivery Order SPE2DB22D1106-SPE2DB25FEXZ6

Award Date 7/15/25
Potential Completion Date 7/16/25
Potential Value $7.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of LIDOCAINE 5% PATCH 30S to the Medical Supply Chain, a division of the Defense Logistics Agency (DLA). The $17,441.85 firm fixed-price delivery order contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 23, 2024. The contract is not set aside and has an ultimate completion date of August 26, 2024. This award is likely part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,344.44 firm-fixed-price delivery order is for LIDOCAINE 5% PATCH 30S and has a completion date of June 26, 2025. The contract is not set-aside and is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global...
This federal contract award is for the delivery of LIDOCAINE 5% PATCH 30S to the Defense Logistics Agency (DLA), a defense agency. The $1,589.00 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of July 11, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp also holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of LIDOCAINE 5% PATCH 30S medical products to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $2,228.38 firm-fixed-price contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of March 22, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999...
This federal contract award is for the delivery of LIDOCAINE 5% PATCH 30S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a firm fixed price of $1,731.28. The contract has an ultimate completion date of May 19, 2025 and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award is for the delivery of LIDOCAINE 5% PATCH 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $6,672.66 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., on September 18, 2023, with a completion date of September 19, 2023. The contract does not have a set-aside designation, indicating it was competitively awarded. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,645.06 firm fixed-price delivery order is for the provision of LIDOCAINE 5% PATCH 30S, with a contract completion date of May 28, 2025. The award is not set-aside and represents an individual delivery order against Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award is for the delivery of LIDOCAINE 5% PATCH 30S medical products to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $3,353.02. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of June 9, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of 4564544784 LIDOCAINE 5% PATCH 30S to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The firm-fixed-price contract award, valued at $7,083.78, has a completion date of May 9, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award is for the delivery of LIDOCAINE 5% PATCH 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,409.28 delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has an ultimate completion date of August 2, 2021 and was awarded on July 30, 2021. It is a firm fixed-price delivery order contract without any set-aside designation, indicating open competition....
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FEXZ6
    Delivery Order

The federal contract award is for the delivery of LIDOCAINE 5% PATCH 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The $7,171.74 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 15, 2025, with a completion date of July 16, 2025. The contract is not set-aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 10/14/25, 10:50 AM